Erez Raphael - 19 Jan 2021 Form 4/A - Amendment Insider Report for DarioHealth Corp. (DRIO)

Role
Chief Executive Officer, Director, 10%+ Owner
Signature
/s/ Erez Raphael
Issuer symbol
DRIO
Transactions as of
19 Jan 2021
Net transactions value
$0
Form type
4/A - Amendment
Filing time
20 May 2021, 16:10:58 UTC
Date Of Original Report
22 Jan 2021
Next filing
19 Jul 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DRIO Common Stock Award $0 +2,268 +0.43% $0.000000 530,768 19 Jan 2021 Direct F1
transaction DRIO Restricted Stock Grant Award $0 +413,158 +78% $0.000000 943,926 19 Jan 2021 Direct F2
holding DRIO Common Stock 37,876 19 Jan 2021 By Dicilyon Consulting and Investment Ltd. F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting person was awarded such securities in exchange for waiving compensation owed for the first quarter of 2021.
F2 The shares vest over three years as follows: 8.333% shall vest on March 31, 2021, and the remaining shares vest in 11 equal instalments every 3 months thereafter.
F3 The amount shown represents the beneficial ownership of the issuer's securities held by Dicilyon Consulting and Investment Ltd. which may be deemed to be attributable to Mr. Raphael because Mr. Raphael possesses voting and dispositive power over the securities held by Dicilyon Consulting and Investment Ltd. by virtue of a proxy. Mr. Raphael disclaims beneficial ownership of the securities set forth herein.